COVID-19 infection in patients with intestinal failure: UK experience

P J Allan 1, T Ambrose 1, C Mountford 2, A Bond 3, C Donnellan 4, R Boyle 5, C Calvert 6, E Cernat 7, E Clarke 8, S C Cooper 9, S Donnelly 10, B Evans 11, M Glynn 12, R Hewett 13, A S Holohan 14, E F Leitch 15, J Louis-Auguste 16, S Mehta 17, S Naik 18, J Nightingale 19, G Rafferty 20, A Rodrigues 21, L Sharkey 22, M Small 10, A Teubner 23, A Urs 24, N Wyer 25, S Lal 23 26 Affiliations expand PMID: 33586170 PMCID: PMC8013499 DOI: 10.1002/jpen.2087 Abstract Background: The direct effect of the coronavirus disease 2019 (COVID-19) pandemic on patients with intestinal failure (IF) has…

Read More

The Long and Short of IT: intestinal failure-associated liver disease (IFALD) in adults

The Long and Short of IT: intestinal failure-associated liver disease (IFALD) in adults-recommendations for early diagnosis and intestinal transplantation Jeremy Mark Woodward 1, Dunecan Massey 1, Lisa Sharkey 1 Affiliations expand PMID: 31885838 PMCID: PMC6914300 DOI: 10.1136/flgastro-2018-101069 Abstract Intestinal failure-associated liver disease (IFALD) often presents in adults unexpectedly with advanced disease. Non-invasive tests can be falsely reassuring. Patients with ‘ultrashort’ intestine (<20 cm) ending…

Read More

Fatal breakthrough mucormycosis in a multivisceral transplant patient receiving micafungin

John R Louis-Auguste 1, Christianne Micallef 2, Tim Ambrose 3, Sara Upponi 4, Andrew J Butler 5, Dunecan Massey 3, Stephen J Middleton 3, Neil Russell 5, Charlotte S Rutter 6, Lisa M Sharkey 3, Jeremy Woodward 3, Effrossyni Gkrania-Klotsas 7, David A Enoch 2 Affiliations expand PMID: 29942755 PMCID: PMC6010962 DOI: 10.1016/j.idcr.2018.03.017 Free PMC article Abstract Introduction: Antifungal agents are routinely used in the post-transplant setting for both prophylaxis and treatment of presumed and proven fungal infections. Micafungin is an echinocandin-class antifungal with broad…

Read More